19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



Facebook    

 

SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace

 

 

 

 


powered by centersite dot net
Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
Kids of Opioid-Using Parents May Be More Likely to Attempt SuicideCholesterol Levels Improving Among U.S. KidsEarlier Bedtimes Help Kids Fight Obesity1 in 5 Kids Don't Strap on Helmets Before BikingParents, Here's How to Protect Your Child During Measles OutbreaksMore Than 600,000 Opioid Abusers Raising Kids in U.S.2 of 3 Parents Read Texts While DrivingFear of Dentist May Start Early for Minority Kids -- With Good ReasonMilitary Tourniquets Might Save Kids' Lives During School ShootingsE-Cigarettes Used in 5% of U.S. Homes With KidsMany Kids With Chronic Illness Are Still Happy: StudyDiet Sodas May Not Help Kids Cut CaloriesAsthma Inhalers Incorrectly Used by Most Kids in StudyNewer Diabetes Drug Shows Promise in Kids, TeensBenlysta Approved for Children With LupusParents, Protect Your Kids as Measles Outbreaks SpreadHow Much Does Your Kid Weigh? Chances Are, You're UnderestimatingFor Kids, Obesity and Mental Health Woes Often Go Hand-in-HandWhy Kids Should Play More Than One SportBetter Food Assistance Programs Might Lower Childhood Obesity RatesMany U.S. Kids Don't Drink Enough Water, and Obesity May Be the ResultStrict Blood Pressure Limits for Kids Tied to Heart Health LaterAlmost Half of Young Asthma Patients Misuse InhalersCan Games and Apps Help Your Kids Learn?Kids Can Get UTIs, TooInactive Lifestyle Begins as Early as Age 7: StudyWhy the HPV Vaccine Is More Important Than EverMore Time Spent in Sports, Faster Healing From ConcussionHow to Cut Your Kids' Sugar IntakeLiving Near Major Roads Can Slow Kids' Development: StudySuicidal Behavior Nearly Doubles Among U.S. KidsTeaching Kids the Importance of an ApologyAHA News: Kids With High Blood Pressure Need Smooth Transition to Adult CarePot During Pregnancy May Raise Child's Psychosis RiskMost Parents Want Age Limits on Football TacklingKids Who Specialize in One Sport Too Early Are Likely to Get Hurt: StudyHealth Tip: Responsibilities of Non-VaccinationThe 1-Parent Family and Kids' Health RisksPesticides Tied to Autism Risk in KidsStrengthening Family Ties Through Online GamingReworked Nasal Flu Vaccine Looks Good for Kids, Pediatricians' Group SaysMore U.S. Teens, Kids Seeking Mental Health Care in ERsAHA News: Overweight Kids at Higher Risk for Blood Clots as AdultsHow to Protect Your Kids From DrowningFewer Boys Are Suffering Head Injuries, But Rate Rises for GirlsWhen Can Kids Return to Play After a Concussion?One-Third of U.S. Kids Have Back Pain, Study SaysMany Parents Think Vaping Around Kids Is FineTime Change Tougher for Kids With Mental Health IssuesLargest Study Ever Finds No Link Between Measles Vaccine, Autism
Questions and AnswersVideosLinksBook Reviews
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Parenting

Benlysta Approved for Children With Lupus

HealthDay News
by -- Scott Roberts
Updated: Apr 29th 2019

MONDAY, April 29, 2019 (HealthDay News) -- The intravenous drug Benlysta (belimumab) has been approved by the U.S. Food and Drug Administration to treat children with lupus, a chronic disease that triggers inflammation and damages tissues and organs throughout the body.

Approved for adults since 2011, Benlysta is the first lupus treatment in the United States approved for children, the agency said in a news release.

"While there is no cure for lupus, treatment can help our youngest patients control their disease with the hope of improving their quality of life and lowering their risk of long-term organ damage and disability," said Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research.

Though rare, childhood lupus typically is more serious than is lupus among adults. Children are at higher risk for developing serious organ damage and other complications, the FDA said.

Benlysta was clinically evaluated among 93 children with the disease. Those who received Benlysta plus standard therapy had a lower risk of a severe flare, the agency said.

The drug's label includes warnings for increased risk of death, serious infections, allergic-like reactions and depression. The drug should not be given at the same time as a person gets a live vaccine, the agency warned.

The drug's most common side effects include nausea, diarrhea and fever. Given the medication's history for causing allergic-like reactions, health professionals are advised to pre-treat users with an antihistamine, the FDA said.

Benlysta is produced by GlaxoSmithKline, based in the United Kingdom.

More information

Visit the FDA to learn more.